One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1097/hs9.0000000000000860
Copy DOI
Export
Save
Share
Cite Journal: HemaSphere |  Publication Date: Apr 1, 2023 |
 Citations: 4 |  License type: CC BY-NC-ND 4.0 |
Affiliation: Hospital Universitario La Paz, Hospital Del Mar, Roche (Switzerland), Kobe City Medical Center General Hospital, National Cancer Center Hospital East, Willamette Valley Cancer Institute and Research Center, Scripps MD Anderson Cancer Center, Hospital de Clínicas de Porto Alegre, University Hospital Cologne, Centro de Pesquisas Oncológicas
Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
